Your browser doesn't support javascript.
loading
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).
Ocio, E M; Richardson, P G; Rajkumar, S V; Palumbo, A; Mateos, M V; Orlowski, R; Kumar, S; Usmani, S; Roodman, D; Niesvizky, R; Einsele, H; Anderson, K C; Dimopoulos, M A; Avet-Loiseau, H; Mellqvist, U-H; Turesson, I; Merlini, G; Schots, R; McCarthy, P; Bergsagel, L; Chim, C S; Lahuerta, J J; Shah, J; Reiman, A; Mikhael, J; Zweegman, S; Lonial, S; Comenzo, R; Chng, W J; Moreau, P; Sonneveld, P; Ludwig, H; Durie, B G M; Miguel, J F S.
Afiliação
  • Ocio EM; Department of Hematology, University Hospital and Cancer Research Center, University of Salamanca-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
  • Richardson PG; Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Rajkumar SV; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Palumbo A; Department of Hematology, University of Torino, Torino, Italy.
  • Mateos MV; Department of Hematology, University Hospital and Cancer Research Center, University of Salamanca-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain.
  • Orlowski R; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Kumar S; Department of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Usmani S; M.I.R.T. UAMS, Little Rock, AR, USA.
  • Roodman D; Director of Hematology/Oncology, Indiana University, Indianapolis, IN, USA.
  • Niesvizky R; Department of Hematology, Weill Cornell Medical College, New York, NY, USA.
  • Einsele H; Department of Internal Medicine, University of Wurzburg, Wurzburg, Germany.
  • Anderson KC; Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Dimopoulos MA; School of Medicine, University of Athens, Athens, Greece.
  • Avet-Loiseau H; Department of Hematology, University of Toulouse, Toulouse, France.
  • Mellqvist UH; Department of Medicine, Section of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Turesson I; Department of Medicine, Section of Hematology, Skane University Hospital, Malmo, Sweden.
  • Merlini G; Department of Molecular Medicine, Univeristy of Pavia, Pavia, Italy.
  • Schots R; Department of Clinical Hematology and Stem Cell Laboratory, University Ziekenhuis, Brussels, Belgium.
  • McCarthy P; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Bergsagel L; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Chim CS; Department of Hematology, Queen Mary Hospital, Hong Kong.
  • Lahuerta JJ; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Shah J; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Reiman A; Department of Oncology, University of New Brunswick, Saint John Regional Hospital, St John, NB, Canada.
  • Mikhael J; Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA.
  • Zweegman S; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Lonial S; Department of Hematology and Medical Oncology, Shanghai Chang Zheng Hospital, Atlanta, GA, USA.
  • Comenzo R; Department of Hematology, Tufts Medical School, Boston, MA, USA.
  • Chng WJ; Department of Hematology Oncology, National University Cancer Institute, Singapore.
  • Moreau P; Department of Hematology, University Hospital, Nantes, France.
  • Sonneveld P; Department of Hematology, Erasmus MC, Rotterdam, The Netherlands.
  • Ludwig H; Department of Medicine, Center for Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria.
  • Durie BG; Oschin Cancer Center, Los Angeles, CA, USA.
  • Miguel JF; 1] Department of Hematology, University Hospital and Cancer Research Center, University of Salamanca-IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain [2] Department of Clinical and Translational Medicine, University of Navarra, Pamplona, Spain.
Leukemia ; 28(3): 525-42, 2014 Mar.
Article em En | MEDLINE | ID: mdl-24253022

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo / Antineoplásicos Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Espanha